WhatsApp
backNews Article

Medi Assist Reports 19% Rise in H1 FY27 EBITDA to ₹97.2 Cr with Margins Expanding to 20.3%

Operating revenue grows 13% to ₹478 Cr while profit after tax rises 59.5%; Board approves ₹49.3 Cr share buyback

Medi Assist Healthcare Services Limited reported a 13% increase in operating revenue to ₹478.0 Cr and a 19% rise in EBITDA to ₹97.2 Cr for H1 FY27, with EBITDA margins expanding by 103 basis points to 20.3%. The company achieved 47% profit before tax growth and 59.5% profit after tax growth, strengthened by technology monetisation and full integration of Paramount operations. Additionally, Medi Assist approved a ₹49.3 Cr share buyback funded from internal cash flows.

14 hours ago|MEDIASSIST-0.14%
Medi Assist Healthcare Services LimitedMEDIASSISTGeneral / Other

Medi Assist Healthcare Services Limited

General / Other

Medi Assist Healthcare Services Limited announced strong H1 FY27 financial results, with EBITDA rising 19% to ₹97.2 Cr and margins expanding to 20.3%, driven by growth in technology revenue and full integration of Paramount operations. Operating revenue increased 13% to ₹478.0 Cr, while profit after tax surged 59.5%.

Medi Assist achieved operating revenue of ₹478.0 Cr for the six months ended September 2026, a 13.0% increase year-on-year, supported by advances in technology monetisation and insurance services.

The company’s EBITDA rose 19.0% to ₹97.2 Cr in H1 FY27, with EBITDA margins improving 103 basis points to 20.3%, reflecting operating leverage from Paramount integration and growth in SaaS and licensing revenue.

Profit before tax grew 47.0% year-on-year, while profit after tax increased 59.5%, demonstrating robust bottom-line improvement.

Medi Assist retained market leadership in group health benefits with a 34.1% market share, up 182 basis points year-on-year, and group premiums under management grew 21.8% to ₹13,939 Cr.

SaaS and licensing revenues surged 83.8% year-on-year, totaling ₹18.1 Cr in H1 FY27, with ongoing insurer adoption expected to boost further revenue from the technology stack in the second half of the fiscal year.

Highlights

  • Operating revenue for H1 FY27 rose 13.0% to ₹478.0 Cr.
  • EBITDA increased 19.0% YoY to ₹97.2 Cr, with margins expanding to 20.3%.
  • Profit after tax surged 59.5% and profit before tax grew 47.0%.
  • Group health benefits market share reached 34.1%, up 182 bps YoY.
  • SaaS and licensing revenue hit ₹18.1 Cr, up 83.8% YoY.
  • Paramount fully integrated, driving operating leverage and cash flow generation. Share buyback approved up to ₹49.3 Cr funded from internal cash flow.

Key Data Snapshot

Operating Revenue H1 FY27₹478.0 Cr
EBITDA H1 FY27₹97.2 Cr
EBITDA Margins H1 FY2720.3%
Profit Before Tax Growth YoY47.0%
Profit After Tax Growth YoY59.5%
Group Health Benefits Market Share34.1% (+182 bps YoY)
Group Premiums under Management H1 FY27₹13,939 Cr
SaaS and Licensing Revenue H1 FY27₹18.1 Cr
Share Buyback Amount Approved~₹49.3 Cr
Cash and Cash Equivalents₹268.3 Cr

What happened

  • Medi Assist reported a 13% increase in operating revenue to ₹478.0 Cr in H1 FY27.
  • EBITDA rose 19.0% to ₹97.2 Cr, with margins expanding to 20.3%.
  • Profit before tax increased 47%, and profit after tax grew by nearly 60%.
  • Paramount operations were fully integrated, contributing to operating leverage.
  • The Board approved a share buyback of approximately ₹49.3 Cr, funded by internal cash flows.

Key details

  • Group health benefits market share rose to 34.1%, a 182 basis point increase from the previous year.
  • Group premiums under management grew 21.8% year-on-year to ₹13,939 Cr.
  • SaaS and licensing revenue grew 83.8% YoY to ₹18.1 Cr in H1 FY27, with insurer adoption increasing.
  • Medi Assist prevented ₹304 Cr in fraud, waste, and abuse using its MAven Guard system.
  • Mayfair's international expansion reported ₹20.7 Cr revenue in H1 FY27, with new platform additions in Southeast Asia.

Strategic context

  • Technology monetisation and insurer adoption are key growth drivers.
  • Paramount integration supports margin expansion and cash flow generation.
  • Share buyback reflects capital allocation discipline and confidence in long-term earnings.
  • International expansion via Mayfair aims to increase presence in 185 countries globally.

Background and context

  • Medi Assist acts as a health benefits administrator connecting insurance companies, policyholders, healthcare providers, and government bodies.
  • Mayfair We Care subsidiary provides international health benefits administration in 185 countries.
  • The company is listed on the NSE (MEDIASSIST) and BSE (Scrip Code: 544088).

More News on General / Other

View all

Latest corporate announcements and market updates in General / Other.

View all news
Medi Assist Reports 19% Rise in H1 FY27 EBITDA to ₹97.2 | Stockk News